Reaction
Immune-Mediated Encephalopathy reporting signals
As of the last recalculation, Immune-Mediated Encephalopathy appears in 87 FAERS reports alongside 2 co-occurring drug terms. The strongest observed disproportionality signal is NIVOLUMAB (PRR 209.4).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nivolumab | 43 | 209.4 | 209.5 |
| Ipilimumab | 18 | 125.5 | 125.6 |